1. Joints - The Foundation of Movement Joints are the moving links in a robotic arm. They let the arm bend, rotate, or change ...

After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...

Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and ...

Samsung said Tuesday it had decided to invest in Phrontline Biopharma, a Chinese biotechnology firm with an antibody-drug conjugate platform and pipeline, through Samsung Life Science Fund. Samsung ...

VARCES, France (AP) — President Emmanuel Macron on Thursday unveiled a new program meant to bolster France’s armed forces by training thousands of volunteers aged 18 and 19 starting next year, part of ...

TIOBE Index for December 2025: Top 10 Most Popular Programming Languages Your email has been sent December’s TIOBE Index lands with a quieter top tier but a livelier shuffle just beneath it. The main ...

Montreal, Quebec--(Newsfile Corp. - December 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Marguerita is a Certified Financial Planner (CFP), Chartered Retirement Planning Counselor ...

Antibody–drug conjugates have emerged as a powerful tool to deliver highly targeted cancer therapies. Next-generation antibody-drug conjugate designs aim to push the envelope even further.